QQ登录

只需要一步,快速开始

 注册地址  找回密码
查看: 4458|回复: 2
打印 上一主题 下一主题

B题第二问标准答案如下,求SAS达人解释

[复制链接]
字体大小: 正常 放大
末代末        

1

主题

0

听众

17

积分

升级  12.63%

该用户从未签到

新人进步奖

跳转到指定楼层
1#
发表于 2006-9-18 05:06 |只看该作者 |倒序浏览
|招呼Ta 关注Ta

一个美国教授写的B题第二问答案(求助,用SAS做的,我看不懂!)

我贴在我的博客里了

http://blog.sina.com.cn/u/1244765643

是从一个美国网站上找到的,真的看不懂,因为不会用SAS

另外,请看懂的或者看明白了的同仁能慷慨一下 

与我联系联系 教教我 

真的很急!!!

在这里先谢了!!
PS:本来前天就搜到了的 但是老师不让外传 但现在实在来不及了
 我们明天8点交卷 我现在在武汉

就算不行也希望和大家交个朋友
下面是一些片段


Repeated CD4 counts data from AIDS clinical trial.

Source: AIDS Clinical Trial Group 193A Study. 
Data courtesy of Dr. Keith Henry.

Reference: Henry, K., Erice, A., Tierney, C., Balfour, H.H. Jr, Fischl, M.A.,
Kmack, A., Liou, S.H., Kenton, A., Hirsch, M.S., Phair, J., Martinez, A. 
and Kahn J.O. for the AIDS Clinical Trial Group 193A Study Team (1998). 
A randomized, controlled, double-blind study comparing the survival benefit of 
four different reverse transcriptase inhibitor therapies (three-drug, two-drug,
and alternating drug) for the treatment of advanced AIDS. Journal of Acquired 
Immune Deficiency Syndromes and Human Retrovirology, 19, 339-349.


Description:

The data are from a randomized, double-blind, study of AIDS patients with 
advanced immune suppression (CD4 counts of less than or equal to 50 cells/mm^3).
Patients in AIDS Clinical Trial Group (ACTG) Study 193A were randomized to 
dual or triple combinations of HIV-1 reverse transcriptase inhibitors. 
Specifically, patients were randomized to one of four daily regimens containing
600mg of zidovudine: zidovudine alternating monthly with 400mg didanosine;
zidovudine plus 2.25mg of zalcitabine; zidovudine plus 400mg of didanosine; 
or zidovudine plus 400mg of didanosine plus 400mg of nevirapine (triple therapy). 
Measurements of CD4 counts were scheduled to be collected at baseline and at 
8-week intervals during follow-up. However, the CD4 count data are unbalanced 
due to mistimed measurements and missing data that resulted from skipped visits
and dropout. The number of measurements of CD4 counts during the first 40 
weeks of follow-up varied from 1 to 9, with a median of 4. 
The response variable is the log transformed CD4 counts, log(CD4 counts + 1), 
available on 1309 patients.
The categorical variable Treatment is coded 1 = zidovudine alternating monthly 
with 400mg didanosine, 2 = zidovudine plus 2.25mg of zalcitabine, 3 = zidovudine
plus 400mg of didanosine, and 4 = zidovudine plus 400mg of didanosine plus 
400mg of nevirapine. The variable Week represents time since baseline (in weeks).


Variable List: Subject ID, Treatment, Age (years), Gender (1=M, 0=F), Week, log(CD4 count + 1).


 1 2 36.4271 1 0.0000 3.13549421590
 1 2 36.4271 1 7.5714 3.04452243770
 1 2 36.4271 1 15.5714 2.77258872220
 1 2 36.4271 1 23.5714 2.83321334410
 1 2 36.4271 1 32.5714 3.21887582490
 1 2 36.4271 1 40.0000 3.04452243770
 2 4 47.8467 1 0.0000 3.06805293510
 2 4 47.8467 1 8.0000 3.89182029810
......

zan
转播转播0 分享淘帖0 分享分享0 收藏收藏0 支持支持1 反对反对0 微信微信
qnamqj        

1

主题

3

听众

75

积分

升级  73.68%

  • TA的每日心情
    无聊
    2013-7-15 12:48
  • 签到天数: 1 天

    [LV.1]初来乍到

    今天忽然想学学sas,在网上找到了一本教材
    1 s+ b  J/ q1 v5 C5 t* e挺好的,谢谢……(本文来自于数学中国社区,网址为http://www.madio.net/mcm
    回复

    使用道具 举报

    0

    主题

    1

    听众

    3

    积分

    升级  60%

    该用户从未签到

    自我介绍
    学生
    回复

    使用道具 举报

    您需要登录后才可以回帖 登录 | 注册地址

    qq
    收缩
    • 电话咨询

    • 04714969085
    fastpost

    关于我们| 联系我们| 诚征英才| 对外合作| 产品服务| QQ

    手机版|Archiver| |繁體中文 手机客户端  

    蒙公网安备 15010502000194号

    Powered by Discuz! X2.5   © 2001-2013 数学建模网-数学中国 ( 蒙ICP备14002410号-3 蒙BBS备-0002号 )     论坛法律顾问:王兆丰

    GMT+8, 2025-6-2 10:31 , Processed in 0.530642 second(s), 66 queries .

    回顶部